Selected Contribution: Tryptase-induced PAR-2-mediated Ca2+signaling in human airway smooth muscle cells
- 1 August 2001
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 91 (2) , 995-1003
- https://doi.org/10.1152/jappl.2001.91.2.995
Abstract
Tryptase, the major mast cell product, is considered to play an important role in airway inflammation and hyperresponsiveness. Tryptase produces different, sometimes opposite, effects on airway responsiveness (bronchoprotection and/or airway contraction). This study was designed to examine the effect of human lung tryptase and activation of protease-activated receptor (PAR)-2 by synthetic activated peptide (AP) SLIGKV-NH2 on Ca2+ signaling in human airway smooth muscle (HASM) cells. Immunocytochemistry revealed that PAR-2 was expressed by HASM cells. Tryptase (7.5–30 mU/ml) induced a concentration-dependent transient relative rise in cytoplasmic Ca2+ concentration ([Ca2+]i) that reached 207 ± 32 nM (n = 10) measured by indo 1 spectrofluorometry. The protease inhibitors leupeptin or benzamidine (100 μM) abolished tryptase-induced [Ca2+]iincrease. Activation of PAR-2 by AP (1–100 μM) also induced a concentration-dependent transient rise in [Ca2+]i, whereas the reverse peptide produced no effect. There was a homologous desensitization of the [Ca2+]i response on repeated stimulation with tryptase or AP. U-73122, a specific phospholipase C (PLC) antagonist, xestospongin, an inositol trisphosphate (IP3)-receptor antagonist, or thapsigargin, a sarcoplamic Ca2+-ATPase inhibitor, abolished tryptase-induced [Ca2+]iresponse, whereas Ca2+ removal, in the additional presence of EGTA, had no effect. Calphostin C, a protein kinase C inhibitor, increased PAR-2 [Ca2+]i response. Our results indicate that tryptase activates a [Ca2+]iresponse, which appears as PAR-2 mediated in HASM cells. Signal transduction implicates the intracellular Ca2+ store via PLC activation and thus via the IP3 pathway. This study provides evidence that tryptase, which is increasingly recognized as an important mediator in airway inflammation and hyperresponsiveness, is also a potent direct agonist at the site of airway smooth muscle.Keywords
This publication has 44 references indexed in Scilit:
- Spatial and temporal aspects of ACh-induced [Ca2+]ioscillations in porcine tracheal smooth muscleCell Calcium, 2000
- Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblastsJournal of Cellular Physiology, 1998
- Heterogeneity in dynamic regulation of intracellular calcium in airway smooth muscle cellsCanadian Journal of Physiology and Pharmacology, 1997
- [Ca2+]i oscillations induced by muscarinic stimulation in airway smooth muscle cells: receptor subtypes and correlation with the mechanical activityBritish Journal of Pharmacology, 1997
- Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchusEuropean Respiratory Journal, 1997
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Production and characterization of monoclonal antibodies specific for human mast cell tryptaseClinical and Experimental Allergy, 1990
- Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs.Journal of Clinical Investigation, 1989
- Acetylcholine-induced contraction in human isolated bronchial smooth muscle: role of an intracellular calcium storeRespiration Physiology, 1987
- Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesteraseNature, 1985